Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
Eli Lilly's stock drops after surprise profit is reported but full-year outlook was slashed
06:51am, Thursday, 02'nd Nov 2023
Shares of Eli Lilly & Co. LLY, +0.10% dropped 1.8% in premarket trading Thursday, after the drug giant reported a surprise third-quarter profit but slashed its full-year outlook, due primarily to acqu
7 A-Rated Tech Stocks to Buy for November
06:40am, Thursday, 02'nd Nov 2023
Last year wasn't the best year for tech stocks. Some of the biggest names on Wall Street stumbled through the year as companies that were flush with growth during the Covid-19 pandemic adjusted to lea
Eli Lilly beats quarterly revenue estimates on Mounjaro strength
06:36am, Thursday, 02'nd Nov 2023
Eli Lilly beat Wall Street's revenue estimates for the third quarter on Thursday, lifted by strong demand for its diabetes drug Mounjaro that brought in over a billion dollars in sales.
Weight-loss drug maker reports 56% profit surge, as it continues to limit supplies
04:34am, Thursday, 02'nd Nov 2023
Novo Nordisk said Thursday it's still struggling to meet demand for its wildly popular weight-loss medications as its third-quarter profit jumped.
Curious about Lilly (LLY) Q3 Performance? Explore Wall Street Estimates for Key Metrics
10:34am, Wednesday, 01'st Nov 2023
Evaluate the expected performance of Lilly (LLY) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics f
Investor patience tested as pharmaceutical stocks take a tumble
06:07am, Wednesday, 01'st Nov 2023
The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of pharmaceutical stock earnings isn't helping sector perfor
Why Beam and Verve Therapeutics Shares Soared While Eli Lilly Soured Today
07:09pm, Tuesday, 31'st Oct 2023
The trio was involved in a deal for gene-editing programs. The arrangement is potentially worth $600 million.
AI-Powered Investing: 3 Promising Stocks for 2024
04:48pm, Tuesday, 31'st Oct 2023
Stock predictions by AI (artificial intelligence) are becoming more popular with investors. More actively managed ETFs are launching driven by AI.
Verve Stock Soars On $250 Million Eli Lilly Deal
01:54pm, Tuesday, 31'st Oct 2023
Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed.
Eli Lilly Stock Has Quadrupled in 3 Years. Could a Weight-Loss Drug Approval Make It Happen Again?
10:12am, Tuesday, 31'st Oct 2023
Speculation and hype created the bulk of Eli Lilly's bullishness of late rather than plausible fundamentals. The rampant speculation around Mounjaro leaves Lilly stock highly vulnerable to bearish vol
Beam Therapeutics up 10% on $600m Lilly deal
08:37am, Tuesday, 31'st Oct 2023
Shares in Beam Therapeutics Inc were up 10% premarket following a deal to sell rights to a licensing deal with Verve Therapeutics to Eli Lilly and Co (NYSE:LLY). An upfront $250 million cash and pap
Busy Week for Earnings, Fed, Reports; MCD, ON Beat in Q3
12:03pm, Monday, 30'th Oct 2023
Mid-October near-term highs have given way to lower trading levels for the most part in the past couple weeks.
Albemarle Vs. Eli Lilly: 1 Potentially Set To Soar And 1 Bubble Stock To Ignore
07:05am, Monday, 30'th Oct 2023
Valuation and fundamentals always matter, driving 97% of long-term stock returns. The market is capable of incredible "fat pitch" discounts and also creates insane bubbles. Albemarle Corporation is th
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
08:45am, Saturday, 28'th Oct 2023
Roche spent $7.1 billion on a company, primarily because of an IBD therapy. Pfizer just got approval for a pill to treat ulcerative colitis.
Three-Stock Lunch: McDonald's, Eli Lilly and Airbnb
03:43pm, Friday, 27'th Oct 2023
Art Hogan, Riley Wealth Management chief market strategist, joins ‘Power Lunch' to discuss three stocks: McDonald's, Eli Lilly and Airbnb.
